Product Details

Sandoz Sertraline

Sertraline HCl
50 mg
Capsule


DIN/PIN/NPN

02245160

Manufacturer

Sandoz Canada Inc.

Formulary Listing Date

2003-01-30  

Unit Price

0.3032

Amount MOH Pays

0.3032

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Sertraline HCl: Sertraline therapy should be discontinued for 2 weeks before starting irreversible monoamine oxidase inhibitors (MAOI). Similarly irreversible MAOI should be discontinued for 2 weeks before starting sertraline.

ATC Code

N06AB06

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
01962817 Zoloft 1.9700 0.3032
02240484 Teva-Sertraline 0.3032 0.3032
02469634 Sertraline 0.3032 0.3032
02386089 Sertraline 0.3032 0.3032
02353539 Sertraline 0.3032 0.3032
02245160 Sandoz Sertraline 0.3032 0.3032
02244839 PMS-Sertraline 0.3032 0.3032
02488442 NRA-Sertraline 0.3032 0.3032
02402394 Mint-Sertraline 0.3032 0.3032
02399423 Mar-Sertraline 0.3032 0.3032
02357151 Jamp-Sertraline 0.3032 0.3032
02287404 Co Sertraline 0.3032 0.3032
02390914 Auro-Sertraline 0.3032 0.3032
02238281 Apo-Sertraline 0.3032 0.3032
02477890 AG-Sertraline 0.3032 0.3032
02530945 M-Sertraline 0.3032 0.3032
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph